Fingerprint
Dive into the research topics where Yeung-Chul Mun is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
A comprehensive analysis of the role of stem cell transplantation in mantle cell lymphoma: real-world data from the Korean Society of Blood and Marrow Transplantation registry: Stem cell transplantation outcomes in mantle cell lymphoma
The Korean Society of Blood and Marrow Transplantation, Dec 2025, In: Blood Research. 60, 1, 44.Research output: Contribution to journal › Article › peer-review
Open Access -
Author Correction: Odronextamab monotherapy in patients with relapsed/refractory diffuse large B cell lymphoma: primary efficacy and safety analysis in phase 2 ELM-2 trial (Nature Cancer, (2025), 6, 3, (528-539), 10.1038/s43018-025-00921-6)
on behalf of the ELM-2 Investigators, May 2025, In: Nature Cancer. 6, 5, p. 907 1 p.Research output: Contribution to journal › Comment/debate
Open Access -
Correction to: Evidence-based Korean guidelines for the clinical management of multiple myeloma: addressing 12 key clinical questions (Blood Research, (2025), 60, 1, (9), 10.1007/s44313-025-00055-9)
Jung, S., Koh, Y., Kim, M. K., Kim, J. S., Moon, J. H., Min, C., Yoon, D. H., Yoon, S., Lee, J., Hong, C. M., Kang, K., Kwon, J., Kim, K. H., Kim, D. S., Kim, S. Y., Kim, S., Kim, Y. R., Do, Y. R., Mun, Y. & Park, S. & 24 others, , Dec 2025, In: Blood Research. 60, 1, 23.Research output: Contribution to journal › Comment/debate
Open Access1 Scopus citations -
Evidence-based Korean guidelines for the clinical management of multiple myeloma: addressing 12 key clinical questions
Jung, S. H., Koh, Y., Kim, M. K., Kim, J. S., Moon, J. H., Min, C. K., Yoon, D. H., Yoon, S. S., Lee, J. J., Hong, C. M., Kang, K. W., Kwon, J., Kim, K. H., Kim, D. S., Kim, S. Y., Kim, S. H., Kim, Y. R., Do, Y. R., Mun, Y. C. & Park, S. S. & 24 others, , Dec 2025, In: Blood Research. 60, 1, 9.Research output: Contribution to journal › Review article › peer-review
Open Access6 Scopus citations -
Odronextamab monotherapy in patients with relapsed/refractory diffuse large B cell lymphoma: primary efficacy and safety analysis in phase 2 ELM-2 trial
ELM-2 Investigators, Mar 2025, In: Nature Cancer. 6, 3, p. 528-539 12 p.Research output: Contribution to journal › Article › peer-review
Open Access36 Scopus citations